External Scientific Committee

Until 2013, The Cancer Genome Atlas (TCGA) received advice from its External Scientific Committee (ESC), whose membership included patient advocates, senior scientists and clinicians with relevant expertise in cancer, genomics and ethics. The members of the ESC were not principal investigators for or funded by TCGA.

External Scientific Committee Members

MemberTitleInstitutional Affiliation
Mark Chee, Ph.D. Founder, Chief Executive Officer and Chief Scientific Officer Prognosys Biosciences, Inc., La Jolla, Calif.
Lynn Dressler, Dr.P.H. Assistant Professor and Associate Director for Policy and Ethics, Institute for Pharmacogenomics and Individualized Therapy University of North Carolina Eshelman School of Pharmacy, Chapel Hill, N.C.
Geoff Duyk, M.D., Ph.D. Partner Texas Pacific Group Ventures, Menlo Park, Calif.
David E. Housman, Ph.D. Ludwig Professor of Biology; Associate in Neurology and Genetics David H. Kock Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital, Boston
Chanita Hughes-Halbert, Ph.D. Associate Professor of Psychiatry and Director of the Community and Minority Cancer Control Program University of Pennsylvania, Philadelphia
Bruce E. Johnson, M.D. Director; Associate Professor of Medicine Dana-Farber Cancer Institute, Boston, Mass.; Harvard Medical School, Boston, Mass.
Susan M. Love, M.D. President and Medical Director Dr Susan Love Research Foundation, Santa Barbara, Calif.
Jennifer A. Pietenpol, Ph.D. Director and Professor of Biochemistry Vanderbilt-Ingram Cancer Center; Vanderbilt University Medical Center, Nashville, Tenn.
George W. Sledge Jr., M.D. Professor of Oncology Indiana University, Indianapolis, Ind.
Robert H. Waterston, M.D., Ph.D. Professor and Chair University of Washington, Seattle
William P. Bro, B.S. President and Chief Executive Officer Kidney Cancer Association (KCA), Chicago, Ill.
Ronald A. DePinho, M.D. Professor of Medicine (Genetics) Harvard Medical School, Boston, Mass.
Sean Eddy, Ph.D. Investigator; Professor of Computational Biology Howard Hughes Medical Institute; Washington University School of Medicine, St. Louis, Mo.
Steven Henikoff, Ph.D. Investigator Howard Hughes Medical Institute; Fred Hutchinson Cancer Research Center, Seattle, Wash.
Leroy Hood, M.D., Ph.D. President and Director Institute for Systems Biology, Seattle, Wash.
Catherine E. Ivy, M.S. President The Ben and Catherine Ivy Foundation, Palo Alto, Calif.
Frank McCormick, Ph.D. Director and Professor Helen Diller Family Comprehensive Cancer Center; University of California, San Francisco, Calif.
Christopher J. Logothetis, M.D. Professor and Chair of Genitourinary Medical Oncology University of Texas M.D. Anderson Cancer Center, Houston, Texas
Charles Sawyers, M.D. Marie Josée and Henry R. Kravis Chair and the Human Oncology and Pathogenesis Program Chair Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Dennis J. Slamon, M.D., Ph.D. Professor and Chief University of California, Los Angeles, Calif.